2020
P13 Major depressive disorder in patients with wilson’s disease: relationship with liver disease, neurological disease and quality of life
Camarata M, Ala A, Maciejewski K, To U, Zimbrean P, Rubman S, Patel A, Wadhwa A, Coskun A, Apdik T, Tomlin R, Deng Y, Schilsky M. P13 Major depressive disorder in patients with wilson’s disease: relationship with liver disease, neurological disease and quality of life. Gut 2020, 69: a13-a13. DOI: 10.1136/gutjnl-2020-basl.24.Peer-Reviewed Original ResearchMajor depressive disorderQuality of lifeMental health QOLWilson's diseaseNeurological diseasesLiver diseaseDepressive disorderFirst presentationExact testDepression symptomologySeverity of liverLifetime major depressive disorderLiver disease severityFisher's exact testPhysical health QoLSignificant differencesWilcoxon rank sum testMental health problemsRank sum testFIB4 scoreClinical featuresNeurological assessmentPHQ-9PatientsCurrent depression
2019
Quality of life and anxiety in children and adolescents in residential treatment facilities
Molinari A, Andrews J, Zaboski B, Kay B, Hamblin R, Gilbert A, Ramos A, Riemann B, Eken S, Nadeau J, Storch E. Quality of life and anxiety in children and adolescents in residential treatment facilities. Residential Treatment For Children & Youth 2019, 36: 220-234. DOI: 10.1080/0886571x.2018.1476201.Peer-Reviewed Original ResearchResidential treatment facilityAnxiety-related impairmentEffects of anxietyTreatment-seeking populationPotential moderator variablesSevere anxiety disorderChildren/youthQuality of lifeAnxiety disordersModeration effectDepression symptomologyModerator variablesPredictive utilityResearch implicationsAnxietyComorbid depressionTreatment respondersPoor QOLDepressionYouthMultimodal treatmentTreatment facilitiesAdolescentsSymptomologyParents
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply